Correlation Between Structure Therapeutics and PepGen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Structure Therapeutics and PepGen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Structure Therapeutics and PepGen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Structure Therapeutics American and PepGen, you can compare the effects of market volatilities on Structure Therapeutics and PepGen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Structure Therapeutics with a short position of PepGen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Structure Therapeutics and PepGen.

Diversification Opportunities for Structure Therapeutics and PepGen

0.67
  Correlation Coefficient

Poor diversification

The 3 months correlation between Structure and PepGen is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Structure Therapeutics America and PepGen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PepGen and Structure Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Structure Therapeutics American are associated (or correlated) with PepGen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PepGen has no effect on the direction of Structure Therapeutics i.e., Structure Therapeutics and PepGen go up and down completely randomly.

Pair Corralation between Structure Therapeutics and PepGen

Given the investment horizon of 90 days Structure Therapeutics American is expected to generate 0.81 times more return on investment than PepGen. However, Structure Therapeutics American is 1.23 times less risky than PepGen. It trades about -0.02 of its potential returns per unit of risk. PepGen is currently generating about -0.1 per unit of risk. If you would invest  3,787  in Structure Therapeutics American on September 4, 2024 and sell it today you would lose (393.00) from holding Structure Therapeutics American or give up 10.38% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Structure Therapeutics America  vs.  PepGen

 Performance 
       Timeline  
Structure Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Structure Therapeutics American has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental indicators, Structure Therapeutics is not utilizing all of its potentials. The recent stock price agitation, may contribute to short-term losses for the retail investors.
PepGen 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days PepGen has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Structure Therapeutics and PepGen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Structure Therapeutics and PepGen

The main advantage of trading using opposite Structure Therapeutics and PepGen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Structure Therapeutics position performs unexpectedly, PepGen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PepGen will offset losses from the drop in PepGen's long position.
The idea behind Structure Therapeutics American and PepGen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Complementary Tools

Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Money Managers
Screen money managers from public funds and ETFs managed around the world
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope